ABBOTT LABORATORIES Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abbott Laboratories quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2024.
  • Abbott Laboratories Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.18B, a 16.6% increase year-over-year.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$7.09B, a 7.14% increase from 2022.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.64B, a 39% decline from 2021.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$5.49B, a 97.7% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.18B +$234M +16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 -$1.41B +$2.41B +63.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$3.82B -$2.86B -295% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 -$967M -$232M -31.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 -$735M +$407M +35.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 -$1.14B +$5.31B +82.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$6.46B -$2.06B -46.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 -$4.4B -$2.97B -207% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2016 -$1.43B -$882M -160% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 -$550M +$602M +52.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q1 2014 -$1.15B +$3.58B +75.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 -$4.73B -$4.9B -2965% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $165M +$850M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 -$684M -$164M -31.6% Jan 1, 2011 Mar 31, 2011 10-Q 2011-05-06
Q1 2010 -$520M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.